Abcellera Biologics Stock Target Price and Analyst Consensus

ABCL Stock  USD 2.54  0.02  0.79%   
The current analyst and expert consensus on Abcellera Biologics is Strong Buy, with 6 strong buy opinions. The current projected Abcellera Biologics target price consensus is 12.14 with 9 analyst opinions. Check out Macroaxis Advice on Abcellera Biologics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.
The most common way Abcellera Biologics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Abcellera Biologics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Abcellera Biologics. We strongly encourage you to use your own analysis of Abcellera Biologics to validate this buy or sell advice. Abcellera Biologics buy-or-sell recommendation module provides average expert sentiment on the projected Abcellera Biologics target price to derive its highest and lowest estimates based on projected price volatility of 4.6291.
Lowest Forecast
11.05
Highest Forecast
13.48
Target Price
12.14
The value of Gross Profit is estimated to slide to about 27.4 M. Pretax Profit Margin is expected to rise to -6.6 this year. At this time, Abcellera Biologics' Cash is quite stable compared to the past year. Common Stock Shares Outstanding is expected to rise to about 295.1 M this year, although the value of Short and Long Term Debt Total will most likely fall to about 42.9 M.
  
It's important to approach Abcellera Biologics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Abcellera Biologics Target Price Consensus

Abcellera target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Abcellera Biologics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   9  Strong Buy
Most Abcellera analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Abcellera stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Abcellera Biologics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Abcellera Biologics Target Price Projection

Abcellera Biologics' current and average target prices are 2.54 and 12.14, respectively. The current price of Abcellera Biologics is the price at which Abcellera Biologics is currently trading. On the other hand, Abcellera Biologics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Abcellera Biologics Market Quote on 18th of March 2025

Low Price2.4Odds
High Price2.55Odds

2.54

Target Price

Analyst Consensus On Abcellera Biologics Target Price

Low Estimate11.05Odds
High Estimate13.48Odds

12.1429

Historical Lowest Forecast  11.05 Target Price  12.14 Highest Forecast  13.48
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Abcellera Biologics and the information provided on this page.

Abcellera Biologics Analyst Ratings

Abcellera Biologics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Abcellera Biologics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Abcellera Biologics' financials, market performance, and future outlook by experienced professionals. Abcellera Biologics' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Abcellera Biologics price targets

Abcellera Biologics' stock target price is an estimate of its future price, usually made by analysts. Using Abcellera Biologics' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Abcellera Biologics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Abcellera Biologics' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Abcellera Biologics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Abcellera Biologics is a key component of Abcellera Biologics valuation and have some predictive power on the future returns of a Abcellera Biologics.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Abcellera Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.132.527.09
Details
Intrinsic
Valuation
LowRealHigh
0.404.979.54
Details
Naive
Forecast
LowNextHigh
0.052.617.18
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.19-0.15-0.1
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Business Services Idea
Business Services
Invested few shares
Momentum Idea
Momentum
Invested few shares
ESG Investing Idea
ESG Investing
Invested few shares
Cash Cows Idea
Cash Cows
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Dividend Beast Idea
Dividend Beast
Invested over 60 shares
Social Domain Idea
Social Domain
Invested few shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested over 40 shares
Apparel Idea
Apparel
Invested over 40 shares
Casinos Idea
Casinos
Sold over 90 shares
Macroaxis Index Idea
Macroaxis Index
Sold over 90 shares
Utilities Idea
Utilities
Invested over 90 shares
When determining whether Abcellera Biologics is a strong investment it is important to analyze Abcellera Biologics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Abcellera Biologics' future performance. For an informed investment choice regarding Abcellera Stock, refer to the following important reports:
Check out Macroaxis Advice on Abcellera Biologics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.